Bangladesh logged 75,913 measles cases and 560 deaths in 56 days, study finds

When WHO issued its first notice on Bangladesh's measles resurgence in April, it had a one-month snapshot: roughly 19,000 suspected cases and 166 deaths. A peer-reviewed surveillance analysis published on 2 October now puts a national figure on the full wave, and it is far larger.

Nationwide surveillance identified 67,079 suspected and 8,834 confirmed measles cases across 8 administrative divisions during the detection window of March 15–May 27, 2026 [s1]. Combining the two categories, 75,913 cases and 560 deaths were recorded in 56 days [s1] — what the authors describe as Bangladesh's largest recorded measles outbreak [s1].

Who the cases were, and how many were hospitalised

The disease fell, as it almost always does, on the youngest. Children younger than five years made up 81% of cases [s1]. More than 70% of patients — a count of 53,463 — required hospitalisation [s1], a figure that speaks to how sick this cohort was rather than to any abundance of hospital capacity.

The two case-fatality ratios diverge in a telling way. Among suspected cases the ratio was 0.88%; among laboratory-confirmed cases it was 0.99% [s1]. Of the 560 deaths, 472 were reported among suspected cases and 88 among confirmed cases [s1]. The gap between the two counts is a function of how measles is counted in a crisis: most deaths occur in patients who are never laboratory-tested, so the suspected column, not the confirmed one, carries the true human cost of an outbreak this size.

Analysed over April 2–May 27, 2026, the epidemic curve climbed to a peak of 1,829 cases reported in a single day on April 9, 2026 [s1]. The outbreak was not evenly spread. Dhaka division reported the highest incidence, at 82.80 cases per 100,000, followed by Barishal at 65.63 per 100,000 and Rajshahi at 35.22 per 100,000 [s1]. Rangpur reported the lowest, 7.63 per 100,000 [s1].

Why a highly vaccinated country burned

The uncomfortable part of the analysis is that Bangladesh was not, on paper, an under-immunised country. Despite high reported vaccine coverage, transmission persisted amid residual immunity gaps [s1]. The authors point to vaccine stockouts, discontinued vaccination campaigns, and coverage overestimation as the likely contributors [s1].

That last phrase matters. A national coverage number that is reported as high but is in fact inflated does not protect anyone; it simply hides the susceptible children until an importation finds them. Measles is the test case for this failure mode because it is the most transmissible of the vaccine-preventable diseases, and because WHO recommends two doses of vaccine to ensure immunity [s2] — a second dose that stockouts and paused campaigns tend to strip out first.

The response, by the numbers

Bangladesh mounted a reactive campaign that targeted approximately 18,015,064 children aged 6–59 months [s1]. The rollout was slow to start and then caught up fast: coverage stood at 6% on April 16, 2026, and surpassed 100% of the targeted baseline on May 13, 2026 [s1]. The outbreak's own curve turned down over the same weeks, which is the pattern a working campaign produces, though observational data cannot cleanly separate the campaign's effect from the epidemic's natural exhaustion of susceptible children.

Why it is on the breaking desk

Two things make this more than a national story. The first is scale: a country that had spent two decades pushing measles towards elimination recorded three-quarters of its outbreak in under two months. The second is the mechanism, which is portable. Coverage overestimation, a stockout, a paused second-dose campaign — none of those is specific to Bangladesh, and all of them are quietly present in other systems that still report reassuring headline coverage.

Globally, an estimated 95,000 people died from measles in 2024, mostly children under the age of five [s2]. Bangladesh's 560 deaths in 56 days are a reminder of how quickly a single country can move a chunk of that global total, and of how little warning the official coverage figures gave before it did.

What to watch

The surveillance paper is a reconstruction, not a live feed, and its confirmed-case count depends on laboratory capacity that varies by division — so the true burden in the least-tested areas is more likely under- than over-counted. The open question is durability: whether the reactive campaign closed the immunity gap that let this outbreak run, or merely paused it until the next stockout. On the evidence here, the honest answer is that nobody yet knows.

Sources

• Nationwide Surveillance and Control Measures during Large Measles Outbreak, Bangladesh, 2026 — Emerging Infectious Diseases (CDC), 2 October 2026
• Measles (fact sheet) — World Health Organization